Who to call at RAPT Therapeutics, Inc., and when
Fundz watches for the moments RAPT Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day RAPT Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RAPT Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RAPT Therapeutics, Inc.. With Fundz connected, it knows.
RAPT Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
flxbio.comThe seat is still open. No replacement has been named 331 days after this filing.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
RAPT Therapeutics' Chief Medical Officer, Dr. William Ho, will leave the company on December 31, 2025, under a mutually agreed separation with nine months of salary, a full target bonus, and nine months of healthcare continuation. He is expected to stay on as a strategic consultant through December 31, 2026, with equity vesting continuing during that period.
Key Takeaways
The CMO departure is mutually agreed and takes effect December 31, 2025, giving the company a defined transition window.
Severance is conditioned on Dr. Ho signing a release of claims and includes nine months of current salary plus 100% of his FY2025 target bonus, paid on the Separation Date.
3 more takeaways
Related Filings (5)
5 more filings from RAPT Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
RAPT Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.